ChatGPT in pharmacometrics? Potential opportunities and limitations
British Journal of Clinical Pharmacology · 2024-01 · 90 (1) · 360-365
DOI: 10.1111/bcp.15895 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 06.09.2023. Verfasst von Michael E Cloesmeijer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Reproducibility of Results. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SYMPHONY, Netherlands Organization for Scientific Research, Boston Symphony Orchestra.
Abstract (Originalsprache)
The potential of using ChatGPT in pharmacometrics was explored in this study, with a focus on developing a population pharmacokinetic (PK) model for standard half‐life factor VIII. Our results demonstrated that ChatGPT can be utilized to accurately obtain typical PK parameters from literature, generate a population PK model in R and develop an interactive Shiny application to visualize the results. ChatGPT's language generation capabilities enabled the development of R codes with minimal programming knowledge and helped to identify as well fix errors in the code. While ChatGPT presents several advantages, such as its ability to streamline the development process, its use in pharmacometrics also has limitations and challenges, including the accuracy and reliability of AI‐generated data, the lack of transparency and reproducibility regarding codes generated by ChatGPT. Overall, our study demonstrates the potential of using ChatGPT in pharmacometrics, but researchers must carefully evaluate its use for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Department of Pediatric Hematology and Oncology, Erasmus University Medical Center - Sophia Children's Hospital Rotterdam, Rotterdam, The Netherlands.
ORCID-Profile: Michael E Cloesmeijer, Sjoerd F Koopman
Förderung
- SYMPHONY
- Netherlands Organization for Scientific Research
- Boston Symphony Orchestra
Zitieren
APA
Cloesmeijer, M. E., Janssen, A., Koopman, S. F., Cnossen, M. H., Mathôt, R. A. A., & SYMPHONY consortium (2024). ChatGPT in pharmacometrics? Potential opportunities and limitations. British Journal of Clinical Pharmacology, 90(1), 360-365. https://doi.org/10.1111/bcp.15895
Vancouver
Cloesmeijer ME, Janssen A, Koopman SF, Cnossen MH, Mathôt RAA, SYMPHONY consortium. ChatGPT in pharmacometrics? Potential opportunities and limitations. British Journal of Clinical Pharmacology. 2024;90(1):360-365. doi:10.1111/bcp.15895
BibTeX
@article{Cloesmeijer2024,
author = {Cloesmeijer, Michael E and Janssen, Alexander and Koopman, Sjoerd F and Cnossen, Marjon H and Mathôt, Ron A A and SYMPHONY consortium, SYMPHONY consortium},
title = {ChatGPT in pharmacometrics? Potential opportunities and limitations},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
volume = {90},
number = {1},
pages = {360--365},
doi = {10.1111/bcp.15895}
}
EUVIMED